The Rivkin Center awards $1.185 million in  ovarian cancer research grants

Seattle, WA (April 11, 2018) — The Rivkin Center for Ovarian Cancer, a Seattle-based 501(c)(3), announced that it has awarded $1.185 million in ovarian cancer research grants for 2018. The amount funded was a 10% increase from the previous year.

The grant recipients include researchers from the United States, Italy, Australia, and Israel whose research projects focus on topics such as prevention and early detection, DNA repair, chemotherapy resistance and novel therapies including immunotherapy. Sixty-four percent of the awardees are women.

“The projects selected this year have tremendous potential to move the progress of ovarian cancer research forward, and help women live longer, healthier lives,” said Joe White, Executive Director of the Rivkin Center for Ovarian Cancer.

Ovarian cancer is the most deadly gynecological cancer, killing more than 22,000 women in the United States each year. Despite this, ovarian cancer continues to be underfunded by federal funding agencies as compared to other cancers. The Rivkin Center plays a pivotal role in helping the forward progress of ovarian cancer research to improve early detection and discover new life-saving treatments. The Rivkin Center is the largest private funder of international ovarian cancer research and has awarded more than $11 million in


Article originally posted at

Click here for the full story

CategoryAggregator News

Privacy Policy / Terms Of Use

Powered by MMD